Aptevo Research And Development LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1999-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.trubion.com
Study of APVO436 in Patients With AML or MDS
Phase 1
- Conditions
- MDSAML
- Interventions
- Biological: APVO436
- First Posted Date
- 2018-08-27
- Last Posted Date
- 2022-02-10
- Lead Sponsor
- Aptevo Research and Development LLC
- Target Recruit Count
- 136
- Registration Number
- NCT03647800
- Locations
- 🇺🇸
Colorado Blood Cancer Institute, Denver, Colorado, United States
🇺🇸The University of Kansas Clinical Research Center, Westwood, Kansas, United States
🇺🇸University of Texas Southwestern Medical Center, Dallas, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath